Target intelligence / Profile preview

Small intestine brush border enzymes (BBE)

Target
BBE
Molecular classification
Enzyme, Hydrolase, Glycosidase, Peptidase
01

Overview

Small intestine brush border enzymes are a collection of hydrolases anchored to the microvilli of the intestinal epithelium, where they execute the final steps of nutrient digestion. This group includes essential disaccharidases such as sucrase-isomaltase, maltase-glucoamylase, and lactase, as well as various peptidases like aminopeptidase N and dipeptidyl peptidase-4 [1][5]. Their primary biological role is to catalyze the hydrolysis of oligosaccharides and peptides into simple monosaccharides and amino acids, facilitating their subsequent absorption into the systemic circulation [1][2]. In a pharmacological context, these enzymes—specifically the alpha-glucosidases—are the primary targets for drugs used to manage Type 2 Diabetes Mellitus [3][4]. By inhibiting these enzymes, drugs like acarbose delay the breakdown of complex carbohydrates, thereby smoothing out postprandial glucose spikes and improving overall glycemic control [3]. Deficiencies or dysfunction of these enzymes are associated with various malabsorption syndromes, such as lactose intolerance or congenital sucrase-isomaltase deficiency, which lead to gastrointestinal distress when specific substrates are ingested [2][5].

Other names
Intestinal brush border hydrolasesMicrovillar enzymesDisaccharidasesAlpha-glucosidasesIntestinal peptidases
02

Mechanism of action

Competitive inhibition of membrane-bound intestinal alpha-glucoside hydrolase enzymes, which results in delayed glucose absorption and lowering of postprandial hyperglycemia [3][4].

03

Biological functions

Carbohydrate digestionProtein digestionNutrient absorptionHydrolysis of disaccharidesHydrolysis of oligopeptides
04

Disease associations

Type 2 Diabetes MellitusMalabsorption syndromeLactose intoleranceSucrase-isomaltase deficiencyCeliac disease
05

Safety considerations

Gastrointestinal side effects (flatulence, diarrhea, abdominal pain)Malabsorption of complex carbohydratesPotential for elevated liver enzymes with high-dose acarboseHypoglycemia when used in combination with sulfonylureas or insulin
06

Interacting drugs

Acarbose

2 more in the full profile.

07

Biomarkers

Postprandial blood glucose levelsHbA1cHydrogen breath test resultsStool acidity (pH)

Beyond the preview

Go deeper on Small intestine brush border enzymes (BBE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small intestine brush border enzymes (BBE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call